Topoisomerase inhibitors induce apoptosis in thymocytes

doi:10.1016/0167-4889(93)90017-J

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Volume 1175, Issue 2, 17 January 1993, Pages 147-154

https://doi.org/10.1016/0167-4889(93)90017-J Get rights and content

Abstract

The effects of the inhibitors of topoisomerase I and II, camptothecin and etoposide, as well as novobiocin and adriamycin, on the DNA fragmentation and viability of mouse thymocytes in primary culture were examined. All inhibitors were shown to produce dose-dependent internucleosomal DNA cleavage by resolving isolated DNA by agarose-gel electrophoresis. The DNA fragmentation seemed to precede cell death, determined on the basis of LDH release, by a few hours. Etoposide-induced DNA fragmentation progressively increased after incubation and was enhanced by pretreatment with phorbol 12,13-dibutyrate, a phorbol ester capable of activating protein kinase C, whereas camptothecin-induced DNA fragmentation increased progressively after 12 h incubation and was unaffected by phorbol 12,13-dibutyrate-pretreatment. The process was also energy-dependent and required RNA and protein synthesis and protein phosphorylation, since it was inhibited by sodium azide, actinomycin D, cycloheximide and 1-(5-isoquinoline-sulfonyl)-2-methylpiperazine hydrochloride, a protein kinase inhibitor. DNA fragmentation was also inhibited by zinc ions, suggesting the involvement of a specific endonuclease in DNA cleavage. These phenomena are similar to those detected in thymocytes undergoing apoptosis following exposure to glucocorticoids (Cohen, J.J. and Duke, R.C. (1984) J. Immunol. 132, 38-42). Considering that topoisomerases function in cellular proliferation and differentiation by altering DNA topology, the results suggest that topoisomerases have important roles in T-lymphocyte ontogeny in the thymus and are in part involved in the elimination of autoreactive or harmful cells by an apoptotic process.

References (48)

K.G. Miller et al.
J. Biol. Chem.
(1981)
M. Bradford
Anal. Biochem.
(1976)
H. Kizaki et al.
J. Biol. Chem.
(1990)
A.H. Wyllie et al.
Int. Rev. Cytol.
(1980)
F. Ojeda et al.
Cell. Immunol.
(1990)
M.M.S. Heck et al.
J. Biol. Chem.
(1989)
D.S. Samuels et al.
FEBS Lett.
(1989)
Y. Pommier et al.
J. Biol. Chem.
(1990)
K. Suzuki et al.
Biochem. Biophys. Res. Commun.
(1990)
K. Suzuki et al.
Cell. Immunol.
(1991)

A.M. Ferro et al.

J. Biol. Chem.

(1984)

A.A. Corbett et al.

J. Biol. Chem.

(1991)

E. Rothenberg et al.

Dev. Biol.

(1985)

J.C. Wang

Annu. Rev. Biochem.

(1985)

L.F. Liu

Annu. Rev. Biochem.

(1989)

A. Constantinou et al.

Cancer Res.

(1989)

K. Nakaya et al.

Jpn. J. Cancer Res.

(1991)

G.E. Francis et al.

Leukemia

(1987)

G. Taudo et al.

FEBS Lett.

(1984)

C. Jaxel et al.

Biochemistry

(1988)

J.G. Kaplan et al.

J. Mol. Evol.

(1987)

B.L. Fowlkes et al.

Adv. Immunol.

(1990)

J.F.R. Kerr et al.

P.R. Walker et al.

Cancer Res.

(1991)

Cited by (114)

Phorbol 12-myristate 13-acetate stimulation under hypoxia induces nuclear swelling with DNA outflow but not extracellular trap formation of neutrophils
2022, Experimental and Molecular Pathology
Citation Excerpt :
Peripheral blood neutrophils (1 × 106/mL) were exposed to 20 nM PMA for 4 h at 37 °C under normoxic (21% O2) or hypoxic (1% O2) conditions. Apoptosis was induced using etoposide (BioVision, Milpitas, CA, USA), as described previously (Onishi et al., 1993; Masuda et al., 2017). Cells were made to react with fluorescein isothiocyanate-conjugated Annexin V and propidium iodide (PI; Apoptosis Detection Kit; BioVision) according to the manufacturer's instruction and then subjected to FCM.
Neutrophils stand sentinel over infection and possess diverse antimicrobial weapons, including neutrophil extracellular traps (NETs). NETs are composed of web-like extracellular DNA decorated with antimicrobial substances and can trap and eliminate invading microorganisms. Although phorbol 12-myristate 13-acetate (PMA) is a potent NET inducer, previous studies have demonstrated that not all neutrophils exhibit NET formation even if stimulated by PMA at high concentrations. This study first showed that some neutrophils stimulated by PMA displayed a swollen nucleus but not NET formation and that hypoxic environments suppressed the NET release. Next, characterization of PMA-stimulated neutrophils with a swollen nucleus was accomplished by differentiating between suicidal-type NETosis and apoptosis. Furthermore, the significance of the phenomenon was examined using formalin-fixed, paraffin-embedded human lung disease tissues with and without pneumonia. As a result, histone H3 citrullination, DNA outflow, propidium iodide labeling, resistance to DNase I, and suspended actin rearrangement were characteristics of PMA-stimulated neutrophils with a swollen nucleus distinct from neutrophils that underwent either suicidal-type NETosis or apoptosis. Neutrophils stimulated by PMA under hypoxic conditions secreted matrix metalloproteinase-9 cytotoxic to human lung-derived fibroblasts. Further, deposition of neutrophil-derived citrullinated histone H3⁺ chromatin substances in pulmonary lesions was greater in patients with pneumonia than in patients without pneumonia and positively correlated with hypoxia-inducible factor-1α expression. The collective findings suggested that neutrophils activated under hypoxic conditions could be putative modulators of hypoxia-related disease manifestations.
Electromagnetic fields and DNA damage
2009, Pathophysiology
A major concern of the adverse effects of exposure to non-ionizing electromagnetic field (EMF) is cancer induction. Since the majority of cancers are initiated by damage to a cell's genome, studies have been carried out to investigate the effects of electromagnetic fields on DNA and chromosomal structure. Additionally, DNA damage can lead to changes in cellular functions and cell death. Single cell gel electrophoresis, also known as the ‘comet assay’, has been widely used in EMF research to determine DNA damage, reflected as single-strand breaks, double-strand breaks, and crosslinks. Studies have also been carried out to investigate chromosomal conformational changes and micronucleus formation in cells after exposure to EMF. This review describes the comet assay and its utility to qualitatively and quantitatively assess DNA damage, reviews studies that have investigated DNA strand breaks and other changes in DNA structure, and then discusses important lessons learned from our work in this area.
Vitamin K<inf>2</inf>-Mediated Apoptosis in Cancer Cells: Role of Mitochondrial Transmembrane Potential
2008, Vitamins and Hormones
Citation Excerpt :
They concluded that vitamin K2 induced differentiation of leukemia cells which were otherwise resistant to vitamin K2‐inducing apoptosis. Some inducers of differentiation, such as camptothecin and VP‐16, induce apoptosis in cancer cells when their concentrations are higher than those required for induction of differentiation (Barry et al., 1990; Bertrand et al., 1993; Jing et al., 1999; Kaufmann, 1989; Ohnishi et al., 1993). Yaguchi et al. (1997) reported that vitamin K2 analogs such as menaquinone‐3, ‐4, and ‐5, but not K1, effectively induced apoptosis in various types of primary cultured leukemia cells and leukemia cell lines in vitro at a concentration of 1 μM.
Vitamin K₂ induces differentiation and apoptosis in a wide array of human cancer cell lines. Vitamin K₂‐mediated apoptosis proceeds much more slowly than the apoptosis induced by conventional anticancer agents. Thus, it is possible to analyze the underlying mechanism in detail. In this chapter, we focus on the pro‐apoptotic effects of vitamin K₂ on mitochondrial physiology with particular emphasis on changes in mitochondrial membrane potential (ΔΨm). Upon treatment of ovarian cancer TYK‐nu cells with vitamin K₂, superoxide is produced after two to three days, followed shortly thereafter by release of mitochondrial cytochrome c. This is accompanied by other apoptotic features such as characteristic morphological changes and DNA fragmentation by day four. Data suggest that superoxide production might cause damage to mitochondrial membranes, open permeability transition pores, and result in disruption of ΔΨm with subsequent release of cytochrome c. Both vitamin K₂‐induced production of superoxide and reduction of ΔΨm are completely inhibited by α‐tocopherol such that cell viability is retained. Thus, we propose that the loss of ΔΨm caused by superoxide might be the major cause of apoptosis following exposure to vitamin K₂. However, other pathways may be involved since cyclosporin A failed to completely inhibit vitamin K₂‐induced apoptosis.
Involvement of BTBD1 in mesenchymal differentiation
2007, Experimental Cell Research
BTBD1 is a recently cloned BTB-domain-containing protein particularly expressed in skeletal muscle and interacting with DNA topoisomerase 1 (Topo1), a key enzyme of cell survival. We have previously demonstrated that stable overexpression of a N-terminal truncated BTBD1 inhibited ex vivo myogenesis but not adipogenesis of pluripotent C2C12 cells. Here, BTBD1 expression was studied in three models of cellular differentiation: myogenesis (C2C12 cells), adipogenesis (3T3-L1 cells) and osteogenesis (hMADS cells). BTBD1 mRNA was found to be upregulated during myogenesis. At the opposite, we have not observed BTBD1 upregulation in an altered myogenesis cellular model and we observed a downregulation of BTBD1 mRNA expression in adipogenesis. Interestingly, amounts of Topo1 protein, but not Topo1 mRNA, were found to be modulated at the opposite of BTBD1 mRNA. No variation of BTBD1 expression was measured during osteogenesis. Taken together, these results indicate that BTBD1 mRNA is specifically regulated during myogenic and adipogenic differentiation, in relation with Topo1 expression. Moreover, they corroborate observations made previously with truncated BTBD1 and show that BTBD1 is a key protein of balance between adipogenesis and myogenesis. Finally, a transcriptome analysis gave molecular clues to decipher BTBD1 role, with an emphasis on the involvement in ubiquitin/proteasome degradation pathway.
Antiproliferative and newly attributed apoptotic activities from an invasive marine alga: Caulerpa racemosa var. cylindracea
2006, Journal of Experimental Marine Biology and Ecology
Caulerpa racemosa (Forsskål) is a green marine alga which spreads from tropical to warm-water regions. Due to having invasive capacity C. racemosa var. cylindracea is a well-known biological pollution in Mediterranean Sea. One of the most important secondary metabolites of C. racemosa is Caulerpenyne (CPN). In the present study, antiproliferative and apoptotic effects of C. racemosa var. cylindracea extract and purified CPN on two well-known neuroblastoma cell lines, SHSY5Y and Kelly, are investigated. The antiproliferative and, additionally, newly attributed apoptotic effects of both C. racemosa var. cylindracea extract and purified CPN on SHSY5Y and Kelly cell lines have been shown in the present study. IC₅₀ values are 0.59 ± 0.06; 1.06 ± 0.23 g wet alga/methanol and 5.64 ± 0.09; 6.02 ± 0.09 μM CPN for C. racemosa var. cylindracea extract and purified CPN on SHSY5Y and Kelly cell lines, respectively. Percentages of apoptotic cells of SHSY5Y and Kelly in 0, 0.1 and 1 μM CPN conditions were 1.00 ± 0.71, 3.00 ± 0.71 and 49.40 ± 3.78, 39.60 ± 6.19 and 78.00 ± 2.74, 69.40 ± 3.78, respectively. In conclusion, the present study shows the antiproliferative effect of C. racemosa var. cylindracea extract and newly attributed apoptotic effects of C. racemosa var. cylindracea this extract. Compared to other alkylating anticancer drugs, CPN and also C. racemosa var. cylindracea extract might be considered as an alternative native source of antitumor drugs. Inasmuch as both C. racemosa extract and CPN have shown both antiproliferative and apoptotic effects on SHSY5Y and Kelly cell lines, the CPN and CPN derivatives might be considered as multifunctional agents in cell metabolism.
Human primary renal cells as a model for toxicity assessment of chemo-therapeutic drugs
2006, Toxicology in Vitro
Chemo-therapeutic drugs act on cancerous and normal cells non-selectively and often cause organ impairments during treatment. Improving safety or reducing toxicity becomes an important challenge for developing better anticancer drugs. In the present study, effects of selected anticancer drugs (camptothecin, doxorubicin, colchicine, paclitaxel, cisplatin, and carboplatin) on cell viability and proliferation was investigated. The anti-proliferative activity of each drug on cancer cells (human hepatoma HepG2) and human primary renal proximal tubule cells (hRPTECs and LLC-PK1) was determined with the [³H]thymidine incorporation assay. Results indicated all six drugs blocked cell proliferation in cancer and normal cells. When the anti-proliferation potency was ranked in hRPTECs based on EC50 values, camptothecin is the most potent, followed by doxorubicin, paclitaxel, colchicine, cisplatin and carboplatin. Cytotoxicity of drugs to hRPTECs was assessed with the ATP bioluminescence assay. Doxorubicin and cisplatin were known to induce nephrotoxicity in vivo and they were indeed cytotoxic to hRPTECs in our study with EC50 values at 11.2 and 39.6 μM. All other drugs are not cytotoxic in the concentrations tested. These drugs typically displayed separation of EC50s between potency (anti-proliferation) and cytotoxicity. The dose separation provides a concentration range for each drug to act on cell proliferation without induction of significant cytotoxicity. Our results suggest that hRPTEC system can serve as an in vitro model for assessing potential nephrotoxicity of chemo-therapeutic drugs.

View all citing articles on Scopus

View full text

Regular paperTopoisomerase inhibitors induce apoptosis in thymocytes

Abstract

J. Biol. Chem.

Anal. Biochem.

J. Biol. Chem.

Int. Rev. Cytol.

Cell. Immunol.

J. Biol. Chem.

FEBS Lett.

J. Biol. Chem.

Biochem. Biophys. Res. Commun.

Cell. Immunol.

J. Biol. Chem.

J. Biol. Chem.

Dev. Biol.

Annu. Rev. Biochem.

Annu. Rev. Biochem.

Cancer Res.

Jpn. J. Cancer Res.

Leukemia

FEBS Lett.

Biochemistry

J. Mol. Evol.

Adv. Immunol.

Cancer Res.

Regular paper
Topoisomerase inhibitors induce apoptosis in thymocytes